About Minute Molecular Diagnostics
Minute Molecular Diagnostics is a private company based in Evanston, Illinois. It has reported $11,286,760 raised in six offerings on Form D since May 2017.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 15, 2023 | Mar 22, 2023 | $4,223,815fully sold | 11 | $383K | Securities on exerciseRule 506(b) | Form D ↗ |
| Jul 26, 2022 | Aug 10, 2022 | $1,870,000of $4.0M target | 8 | $233K | Debt, OptionsRule 506(b) | Form D ↗ |
| Apr 20, 2021 | Apr 30, 2021 | $1,999,968of $6.0M target | 10 | $199K | EquityRule 506(b) | Form D ↗ |
| Nov 7, 2019 | Nov 22, 2019 | $800,009of $2.0M target | 10 | $80,001 | EquityRule 506(b) | Form D ↗ |
| Jul 27, 2018 | Aug 13, 2018 | $1,092,975of $1.3M target | 9 | $121K | EquityRule 506(b) | Form D ↗ |
| May 12, 2017 | May 23, 2017 | $1,299,993fully sold | 10 | $129K | EquityRule 506(b) | Form D ↗ |
| Total, six offerings | $11,286,760 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Minute Molecular Diagnostics's Form D filed Mar 22, 2023.
Earlier filings also listed Sally McFall (executive officer, last listed May 2017) and Kara Palamountain (executive officer, last listed May 2017).